Q3 defined by greatest drop in product prices since 2016 legalisation of medicinal cannabis products in Australia
Q3 was defined by the greatest drop in product price since early 2016 legalisation of medicinal cannabis products in Australia, as the market has grown 3x year on year and will close 2020 with around 30,000 active patients.
This report will be the fifth major publication from FreshLeaf, which is the leading source of information, data and analysis on the sector.
-Industry revenue expected to grow 3x in 2020 to ~$95M
-Number of available products has doubled in the last year to 150
-Largest YOY drop…